Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

Similar articles for PubMed (Select 21611108)

1.

Differential genetic expression in large versus small clear cell renal cell carcinoma: results from microarray analysis.

Bratslavsky G, Sanford T, Srinivasan R, Aprelikova O, Liu J, Quezado M, Merino M, Linehan WM.

J Cancer. 2011;2:271-9. Epub 2011 May 12.

2.

Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.

Maruschke M, Reuter D, Koczan D, Hakenberg OW, Thiesen HJ.

BJU Int. 2011 Jul;108(2 Pt 2):E29-35. doi: 10.1111/j.1464-410X.2010.09794.x. Epub 2011 Mar 16.

PMID:
21435154
3.

Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins.

Rohan SM, Xiao Y, Liang Y, Dudas ME, Al-Ahmadie HA, Fine SW, Gopalan A, Reuter VE, Rosenblum MK, Russo P, Tickoo SK.

Mod Pathol. 2011 Sep;24(9):1207-20. doi: 10.1038/modpathol.2011.80. Epub 2011 May 20.

4.

Genetic flanking markers refine diagnostic criteria and provide insights into the genetics of Von Hippel Lindau disease.

Seizinger BR, Smith DI, Filling-Katz MR, Neumann H, Green JS, Choyke PL, Anderson KM, Freiman RN, Klauck SM, Whaley J, et al.

Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2864-8.

5.

The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease.

Duffey BG, Choyke PL, Glenn G, Grubb RL, Venzon D, Linehan WM, Walther MM.

J Urol. 2004 Jul;172(1):63-5.

PMID:
15201738
6.

Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney.

Aydin H, Chen L, Cheng L, Vaziri S, He H, Ganapathi R, Delahunt B, Magi-Galluzzi C, Zhou M.

Am J Surg Pathol. 2010 Nov;34(11):1608-21. doi: 10.1097/PAS.0b013e3181f2ee0b.

PMID:
20924276
7.

[Von-Hippel-Lindau gene mutation types. Association of gene expression signatures in clear cell renal cell carcinoma].

Luu VD, Fischer B, von Teichman A, Boysen G, Mertz K, Zimmermann P, Moch H, Schraml P.

Pathologe. 2008 Nov;29 Suppl 2:303-7. doi: 10.1007/s00292-008-1031-1. German.

PMID:
18751980
8.

Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).

Singh RB, Amare Kadam PS.

Urol Oncol. 2013 Oct;31(7):1333-42. doi: 10.1016/j.urolonc.2011.08.012. Epub 2011 Oct 1.

PMID:
21962529
9.

[Heredity in renal and prostatic neoplasia].

Prayer Galetti T, D'Arrigo L, De Zorzi L, Patarnello T.

Arch Ital Urol Androl. 1997 Sep;69(4):241-6. Review. Italian.

PMID:
9417296
10.

Expression profiling of t(12;22) positive clear cell sarcoma of soft tissue cell lines reveals characteristic up-regulation of potential new marker genes including ERBB3.

Schaefer KL, Brachwitz K, Wai DH, Braun Y, Diallo R, Korsching E, Eisenacher M, Voss R, Van Valen F, Baer C, Selle B, Spahn L, Liao SK, Lee KA, Hogendoorn PC, Reifenberger G, Gabbert HE, Poremba C.

Cancer Res. 2004 May 15;64(10):3395-405.

11.

Microarray gene expression profiling and analysis in renal cell carcinoma.

Liou LS, Shi T, Duan ZH, Sadhukhan P, Der SD, Novick AA, Hissong J, Skacel M, Almasan A, DiDonato JA.

BMC Urol. 2004 Jun 22;4:9.

13.

Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data.

Lenburg ME, Liou LS, Gerry NP, Frampton GM, Cohen HT, Christman MF.

BMC Cancer. 2003 Nov 27;3:31.

14.

Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.

Wiesener MS, Münchenhagen PM, Berger I, Morgan NV, Roigas J, Schwiertz A, Jürgensen JS, Gruber G, Maxwell PH, Löning SA, Frei U, Maher ER, Gröne HJ, Eckardt KU.

Cancer Res. 2001 Jul 1;61(13):5215-22.

15.

Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia.

Gunningham SP, Currie MJ, Han C, Turner K, Scott PA, Robinson BA, Harris AL, Fox SB.

Cancer Res. 2001 Apr 1;61(7):3206-11.

16.

Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease.

Phillips JL, Ghadimi BM, Wangsa D, Padilla-Nash H, Worrell R, Hewitt S, Walther M, Linehan WM, Klausner RD, Ried T.

Genes Chromosomes Cancer. 2001 May;31(1):1-9.

PMID:
11284029
18.

Von Hippel-Lindau and myotonic dystrophy of Steinert along with pancreatic neuroendocrine tumor and renal clear cell carcinomal neoplasm: Case report and review of the literature.

Addeo A, Bini R, Viora T, Bonaccorsi L, Leli R.

Int J Surg Case Rep. 2013;4(8):648-50. doi: 10.1016/j.ijscr.2013.03.004. Epub 2013 Mar 29.

19.

Description of 2 angiogenic phenotypes in clear cell renal cell carcinoma.

Edeline J, Mottier S, Vigneau C, Jouan F, Perrin C, Zerrouki S, Fergelot P, Patard JJ, Rioux-Leclercq N.

Hum Pathol. 2012 Nov;43(11):1982-90. doi: 10.1016/j.humpath.2012.01.023. Epub 2012 May 22.

PMID:
22626276
20.

Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery.

Walther MM, Choyke PL, Glenn G, Lyne JC, Rayford W, Venzon D, Linehan WM.

J Urol. 1999 May;161(5):1475-9.

PMID:
10210376
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk